Brookline Capital Acquisition Corp.
If you purchased Brookline Capital Acquisition Corp. securities and would like to join the action, please click "Join This Action" below.
HALPER SADEH LLP ANNOUNCES INVESTIGATION INTO WHETHER THE MERGER OF BROOKLINE CAPITAL ACQUISITION CORP. IS FAIR TO SHAREHOLDERS
March 20, 2022.
New York, New York—Halper Sadeh LLP, a global investor rights law firm, is investigating whether the merger of Brookline Capital Acquisition Corp. (NASDAQ: BCAC) and Apexigen, Inc. is fair to Brookline Capital shareholders.
The investigation concerns whether Brookline Capital and its board violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for Brookline Capital shareholders; and (2) disclose all material information necessary for Brookline Capital shareholders to adequately assess and value the merger consideration. On behalf of Brookline Capital shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.
Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.